Log in
Enquire now
‌

US Patent 9630907 Methods for synthesizing amatoxin building block and amatoxins

Patent 9630907 was granted and assigned to Heidelberg Pharma on April, 2017 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Heidelberg Pharma
Heidelberg Pharma
0
Current Assignee
Heidelberg Pharma
Heidelberg Pharma
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
96309070
Patent Inventor Names
Werner Simon0
Christian Lutz0
Christoph Mueller0
Date of Patent
April 25, 2017
0
Patent Application Number
144141430
Date Filed
July 12, 2013
0
Patent Primary Examiner
‌
Jeanette Lieb
0
Patent abstract

The invention relates to novel methods for synthesizing a synthon for γ,δ-dihydroxyisoleucine 1 (CAS No. 55399-94-5] as building block for the synthesis of amatoxins, and for novel methods for synthesizing amatoxins using such building block.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9630907 Methods for synthesizing amatoxin building block and amatoxins

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.